MetaCap

Apyx Medical Insider Trades

NASDAQ: APYXHealth CareMedical/Dental InstrumentsUSD

2.40+0.01 (+0.42%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Apyx Medical insider activity

Over the last 12 months, Apyx Medical insiders reported 7 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Waldman Lawrence (Director) reporting a transaction in 12,000 shares at $1.88 on Jun 30, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put APYX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

APYX insider transactions

Apyx Medical insider transactions
DateInsiderTypeSharesValueFiling
Jun 30, 2026Waldman LawrenceDirectorTax withholding5,024$22.56KForm 4
Jun 30, 2026Waldman LawrenceDirectorOption exercise12,000$22.56KForm 4
Jun 15, 2026Roman Shawn DavidChief Operating OfficerTax withholding10,533$48.45KForm 4
Jun 15, 2026Roman Shawn DavidChief Operating OfficerOption exercise15,000$48.45KForm 4
Jun 11, 2026Vizirgianakis Stavros G.DirectorAward450,000—Form 4
Mar 15, 2026CITRONOWICZ MOSHESenior Vice PresidentOption exercise37,000$66.60KForm 4
Jan 27, 2026Roman Shawn DavidChief Operating OfficerOption exercise12,000$21.60KForm 4
Aug 13, 2024HILL MATTHEW CChief Financial OfficerBuy5,336$6.03KForm 4
Aug 13, 2024HILL MATTHEW CChief Financial OfficerBuy6,000$6.78KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related